Clinical staging for youth at-risk for serious mental illness
- PMID: 30672153
- DOI: 10.1111/eip.12786
Clinical staging for youth at-risk for serious mental illness
Abstract
Aim: The first aim of this project was to identify a sample of youth who met different stages of risk for the development of a serious mental illness (SMI) based on a published clinical staging model. The second aim was to determine whether participants allocated to the different stages were a good fit to the model by comparing these groups on a range of clinical measures.
Methods: This two-site longitudinal study recruited 243 youth, ages 12 to 25. The sample included (a) 42 healthy controls, (b) 43 non-help seeking individuals with no mental illness but with some risk of SMI, such as having a first-degree relative with a SMI (stage 0), (c) 52 help-seeking youth experiencing distress and possibly mild symptoms of anxiety or depression (stage 1a) and (d) 108 youth with attenuated symptoms of SMI, such as bipolar disorder or psychosis (stage 1b). Participants completed a range of measures assessing depression, anxiety, mania, suicide ideation, attenuated psychotic symptoms, negative symptoms, anhedonia and beliefs about oneself.
Results: There were no clinical differences between HCs and participants in stage 0. For most of the clinical measures, participants in stage 1b had more severe ratings than participants in stages 1a and 0 and HCs; those in stage 1a had more severe ratings than HCs and stage 0 participants.
Conclusions: These results suggest that the staging process used to allocate participants to various stages is a good fit. That is, the clinical ratings followed an ordering effect consistent with that hypothesized in the staging model.
Keywords: bipolar disorder; clinical high risk; depression; psychosis; risk; schizophrenia; youth.
© 2019 John Wiley & Sons Australia, Ltd.
Similar articles
-
Clinical staging for youth at-risk for serious mental illness: A longitudinal perspective.Early Interv Psychiatry. 2021 Oct;15(5):1188-1196. doi: 10.1111/eip.13062. Epub 2020 Oct 9. Early Interv Psychiatry. 2021. PMID: 33037783
-
Family functioning in youth at-risk for serious mental illness.Compr Psychiatry. 2018 Nov;87:17-24. doi: 10.1016/j.comppsych.2018.08.010. Epub 2018 Aug 25. Compr Psychiatry. 2018. PMID: 30193153
-
Youth at-risk for serious mental illness: methods of the PROCAN study.BMC Psychiatry. 2018 Jul 5;18(1):219. doi: 10.1186/s12888-018-1801-0. BMC Psychiatry. 2018. PMID: 29976184 Free PMC article.
-
At-risk studies and clinical antecedents of psychosis, bipolar disorder and depression: a scoping review in the context of clinical staging.Psychol Med. 2019 Jan;49(2):177-189. doi: 10.1017/S0033291718001435. Epub 2018 Jun 4. Psychol Med. 2019. PMID: 29860956
-
[Predicting bipolar disorder: what can we learn from prospective cohort studies?].Encephale. 2015 Feb;41(1):10-6. doi: 10.1016/j.encep.2013.05.004. Epub 2013 Oct 3. Encephale. 2015. PMID: 24094986 Review. French.
Cited by
-
Transdiagnostic Dimensions of Psychiatric Comorbidity in Individuals at Clinical High Risk for Psychosis: A Preliminary Study Informed by HiTOP.Front Psychiatry. 2021 Jan 8;11:614710. doi: 10.3389/fpsyt.2020.614710. eCollection 2020. Front Psychiatry. 2021. PMID: 33488432 Free PMC article.
-
Comorbidities, Depression Severity, and Circadian Rhythms Disturbances as Clinical Correlates of Duration of Untreated Illness in Affective Disorders.Medicina (Kaunas). 2021 May 8;57(5):459. doi: 10.3390/medicina57050459. Medicina (Kaunas). 2021. PMID: 34066782 Free PMC article.
-
Factors Associated with Transition to Serious Mental Illness.Can J Psychiatry. 2024 Feb;69(2):79-88. doi: 10.1177/07067437231195959. Epub 2023 Aug 22. Can J Psychiatry. 2024. PMID: 37606525 Free PMC article.
-
Brain connectomes in youth at risk for serious mental illness: an exploratory analysis.BMC Psychiatry. 2022 Sep 15;22(1):611. doi: 10.1186/s12888-022-04118-4. BMC Psychiatry. 2022. PMID: 36109720 Free PMC article.
-
Inflammation and emotion regulation: a narrative review of evidence and mechanisms in emotion dysregulation disorders.Neuronal Signal. 2023 Nov 15;7(4):NS20220077. doi: 10.1042/NS20220077. eCollection 2023 Dec. Neuronal Signal. 2023. PMID: 38026703 Free PMC article. Review.
References
REFERENCES
-
- Addington, D., Addington, J., & Maticka-Tyndale, E. (1993). Assessing depression in schizophrenia: The Calgary depression scale. British Journal of Psychiatry, 163, 39-44.
-
- Addington, J., Cadenhead, K. S., Cornblatt, B. A., Mathalon, D. H., McGlashan, T. H., Perkins, D. O., et al. (2012). North American Prodrome longitudinal study (NAPLS 2): Overview and recruitment. Schizophrenia Research, 142, 77-82.
-
- Addington, J., Chaves, A., & Addington, D. (2006). Diagnostic stability over one year in first-episode psychosis. Schizophrenia Research, 86, 71-75.
-
- Addington, J., Goldstein, B. I., Wang, J. L., Kennedy, S. H., Bray, S., Lebel, C., … MacQueen, G. (2018). Youth at-risk for serious mental illness: Methods of the PROCAN Study. BMC Psychiatry, 18, 219.
-
- Addington, J., & Tran, L. (2009). Using the brief core schema scales with individuals at clinical high risk of psychosis. Behavioural and Cognitive Psychotherapy, 37, 227-231.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous